A Bayesian Approach to Dose-Response Assessment and Synergy and Its Application to In Vitro Dose-Response Studies

Biometrics

Volumn 66, Issue 4, 2010, Pages 1275-1283

  Hennessey, Violeta G ^a   Rosner, Gary L ^a   Bast, Robert C ^b   Chen, Min Yu ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Combination index method; Drug interaction; Interaction index; Loewe additivity model; Median effect principle

Indexed keywords

BAYESIAN NETWORKS; CELL CULTURE; CONTROLLED DRUG DELIVERY; DISEASES; DRUG DOSAGE; MARKOV PROCESSES; REGRESSION ANALYSIS; UNCERTAINTY ANALYSIS;

ADDITIVITY MODEL; BAYESIAN APPROACHES; COMBINATION INDEX METHOD; DOSE-RESPONSE ASSESSMENTS; DOSE-RESPONSE STUDY; IN-VITRO; INTERACTION INDEX; ITS APPLICATIONS; LOEWE ADDITIVITY MODEL; MEDIAN-EFFECT PRINCIPLE;

DRUG INTERACTIONS;

BAYESIAN ANALYSIS; CANCER; DOSE-RESPONSE RELATIONSHIP; DRUG; EXPERIMENTAL STUDY; INDEX METHOD; MARKOV CHAIN; MONTE CARLO ANALYSIS; REGRESSION ANALYSIS; UNCERTAINTY ANALYSIS; WOMENS HEALTH;

EID: 78650054236     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2010.01403.x     Document Type: Article

References (22)

1. Berenbaum, M. C. (1989). What is synergy Pharmacological Reviews 41, 93-141.
2. Boik, J. C., Newman, R. A., and Boik, R. J. (2008). Quantifying synergism/antagonism using nonlinear mixed-effects modeling: A simulation study. Statistics in Medicine 27, 1040-1061.
3. Chou, T. C. (1976). Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands. Journal of Theroretical Biology 59, 253-276.
4. Chou, T. C. (2006). Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacological Reviews 58, 621-681.
5. Chou, T. C. and Rideout, D. D. (1991). Synergism and Antagonism in Chemotherapy. San Diego Academic Press.
6. Chou, T. C. and Talalay, P. (1984). Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation 22, 27-55.
7. Committee on the Health Risks of Phthalates, National Research Council. (2008). Phthalates and Cumulative Risk Assessment: The Task Ahead. Washington, DC The National Academy Press.
8. Davidian, M. and Giltinan, D. M. (1995). Nonlinear Models for Repeated Measurement Data. Boca Raton, Florida Chapman and Hall/CRC Press.
9. Gelman, A. (2006). Prior distributions for variance parameters in hierarchical models. Bayesian Analysis 1, 515-533.
10. Goldoni, M. and Johansson, C. (2007). A mathematical approach to study combined effects of toxicants in vitro: Evaluation of the Bliss independence criterion and the Loewe additivity model. Toxicology In Vitro Cancer Research 5, 759-769.
11. Greco, W. R., Park, H. S., and Rustum, Y. M. (1990). Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-β-D-arabinofuranosylcytosine. Cancer Research 50, 5318-5327.
12. Greco W. R., Bravo, G., and Parsons J. C. (1995). The search for synergy: A critical review from a response surface perspective. Pharmacolological Reviews 47, 331-385.
13. Hill, A. V. (1910). The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. The Journal of Physiology 40, iv-vii.
14. Lee, J. J. and Kong M. (2007). Confidence intervals of interaction index for assessing multiple drug interaction. Statistics in Biopharaceutical Research. Available at:
15. Lee, J. J., Kong M., Ayers, G. D., and Lotan, R. (2006). SYNERGY. Available at:
16. Lee, J. J., Kong M., Ayers, G. D., and Lotan, R. (2007). Interaction index and different methods for determining drug interaction in combination therapy. Journal of Biopharmaceutical Statistics 17, 461-480.
17. Loewe, S. and Muischnek, H. (1926). Effect of combinations: Mathematical basis of problem. Archives of Experimental Pathology and Pharmacology 114, 312-326.
18. Petersdorf, R. G., Page, W. F., and Thaul, S., editors. (1996). Interactions of Drugs, Biologics, and Chemicals in U.S. Military Forces. Washington, DC The National Academy Press.
19. Rouder, J. N. and Lu, J. (2005). An introduction to Bayesian hierarchical models with an application in theory of signal detection. Psychonomic Bulletin and Review 12, 573-604.
20. Skehan P., Storeng R., and Scudiero D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute 82, 1107-1112.
21. Spiegelhalter, D., Thomas, A., Best, N., and Lunn, D. (2002). WinBUGS 1.4 manual. Available at:
22. Tallarida, R. J. and Raffa, R. B. (1996). Testing for synergism over a range of fixed ratio drug combinations: Replacing the isobologram. Life Sciences 58, 23-28.